Alcon (ALC) Cash from Investing Activities (2009 - 2026)
Alcon (ALC) posted Cash from Investing Activities of -$222.0 million for Q2 2026, down 1.83% on a QoQ basis from -$218.0 million in Q1 2026, and down 44.16% year-over-year from -$397.5 million in Q2 2025.
Analysis
Alcon (ALC) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Alcon has reported Cash from Investing Activities for 11 years, with the latest figure at -$222.0 million in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 44.16% year-over-year to -$222.0 million in Q2 2026; TTM through Jun 2026 was -$1.1 billion, a 4.62% increase from a year earlier, with the FY2025 full-year figure at -$1.3 billion, down 15.17% from the prior year.
- Cash from Investing Activities was -$222.0 million for Q2 2026 at Alcon, down from -$218.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$133.0 million in Q2 2024, with the low at -$852.0 million in Q4 2022.
- Average Cash from Investing Activities over 5 years is -$313.6 million, with a median of -$251.0 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities tumbled 360.31% in 2022, then jumped 74.3% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$852.0 million in 2022, then surged by 56.1% to -$374.0 million in 2023, then gained by 10.96% to -$333.0 million in 2024, then grew by 9.91% to -$300.0 million in 2025, then increased by 26.0% to -$222.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$222.0 million (Q2 2026), -$218.0 million (Q1 2026), and -$300.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | -190.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -222.00 Mn |
| Mar 31, 2026 | -218.00 Mn |
| Dec 31, 2025 | -300.00 Mn |
| Sep 30, 2025 | -312.00 Mn |
| Jun 30, 2025 | -154.00 Mn |
| Dec 31, 2024 | -333.00 Mn |
| Sep 30, 2024 | -483.00 Mn |
| Jun 30, 2024 | -133.00 Mn |
| Mar 31, 2024 | -218.00 Mn |
| Dec 31, 2023 | -374.00 Mn |
| Sep 30, 2023 | -152.00 Mn |
| Jun 30, 2023 | -413.00 Mn |
| Mar 31, 2023 | -155.00 Mn |
| Dec 31, 2022 | -852.00 Mn |
| Sep 30, 2022 | -251.00 Mn |
| Jun 30, 2022 | -159.00 Mn |
| Mar 31, 2022 | -603.00 Mn |
| Dec 31, 2021 | -351.00 Mn |
| Sep 30, 2021 | -204.00 Mn |
| Jun 30, 2021 | -512.00 Mn |